We are live on ! Find out more
KTC

Kistler-Tiffany Companies Portfolio holdings

AUM $616M
1-Year Est. Return 16.74%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$264M
AUM Growth
+$912K
Cap. Flow
-$1.34M
Cap. Flow %
-0.51%
Top 10 Hldgs %
50.97%
Holding
615
New
36
Increased
119
Reduced
95
Closed
19

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$3.36M
2
SCHM icon
Schwab US Mid-Cap ETF
SCHM
+$664K
3
CCK icon
Crown Holdings
CCK
+$571K
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$445K
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$417K

Top Sells

Rank Stock Value
1
MLAB icon
Mesa Laboratories
MLAB
+$6.49M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.35M
3
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$733K
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$561K
5
VTV icon
Vanguard Morningstar Value ETF
VTV
+$438K

Sector Composition

Rank Sector Weight
1 Healthcare 11.67%
2 Technology 6.15%
3 Consumer Staples 4.82%
4 Communication Services 4.41%
5 Financials 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOXX icon
426
iShares Semiconductor ETF
SOXX
$46.2B
$13K ﹤0.01%
180
– –
UN
427
DELISTED
Unilever NV New York Registry Shares
UN
$13K ﹤0.01%
219
– –
CARG icon
428
CarGurus
CARG
$3.29B
$12K ﹤0.01%
400
– –
CCEP icon
429
Coca-Cola Europacific Partners
CCEP
$47.3B
$12K ﹤0.01%
209
– –
DLR icon
430
Digital Realty Trust
DLR
$72.9B
$12K ﹤0.01%
91
– –
NRC icon
431
NRC Health Common Stock
NRC
$456M
$12K ﹤0.01%
202
– –
NVEE
432
DELISTED
NV5 Global
NVEE
$12K ﹤0.01%
716
– –
WAB icon
433
Wabtec
WAB
$49.9B
$12K ﹤0.01%
170
-65
-28% -$4.62K
ARCC icon
434
Ares Capital
ARCC
$14.3B
$11K ﹤0.01%
580
– –
DLTR icon
435
Dollar Tree
DLTR
$24.7B
$11K ﹤0.01%
100
– –
GH icon
436
Guardant Health
GH
$22.2B
$11K ﹤0.01%
170
+70
+70% +$6.17K
HES
437
DELISTED
Hess
HES
$11K ﹤0.01%
175
– –
KMI icon
438
Kinder Morgan
KMI
$70.7B
$11K ﹤0.01%
521
– –
REGN icon
439
Regeneron Pharmaceuticals
REGN
$82.2B
$11K ﹤0.01%
39
– –
VREX icon
440
Varex Imaging
VREX
$778M
$11K ﹤0.01%
371
– –
AYX
441
DELISTED
Alteryx Inc
AYX
$11K ﹤0.01%
+100
New +$12.4K
TLND
442
DELISTED
Talend S.A. American Depositary Shares
TLND
$11K ﹤0.01%
331
– –
AXSM icon
443
Axsome Therapeutics
AXSM
$11.2B
$10K ﹤0.01%
500
– –
DDD icon
444
3D Systems Corp
DDD
$603M
$10K ﹤0.01%
1,167
– –
DGX icon
445
Quest Diagnostics
DGX
$26.2B
$10K ﹤0.01%
94
– –
EFV icon
446
iShares MSCI EAFE Value ETF
EFV
$30.1B
$10K ﹤0.01%
205
– –
EQIX icon
447
Equinix
EQIX
$105B
$10K ﹤0.01%
18
– –
IFN
448
Aberdeen India Fund
IFN
$509M
$10K ﹤0.01%
498
– –
IRBT
449
DELISTED
iRobot
IRBT
$10K ﹤0.01%
162
– –
ITOT icon
450
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$10K ﹤0.01%
152
– –
16 17
18
19 20

Similar funds

FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
NWM
NEIRG Wealth Management North Andover, Massachusetts $542M AUM 10.92% 1-Year Est. Return
KC
KCL Capital New York $714M AUM 77.46% 1-Year Est. Return
EWM
Endurance Wealth Management Providence, Rhode Island $731M AUM 18.41% 1-Year Est. Return
SAM
Sabadell Asset Management Sant Cugat Del Valles, Spain $482M AUM 27.83% 1-Year Est. Return
TWI
Thomas White International Chicago, Illinois $480M AUM 11.77% 1-Year Est. Return
TF
TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return
ECI
EFG Capital International Miami, Florida $432M AUM

Kistler-Tiffany Companies's Q3 2019 Portfolio in Review

As of Q3 2019, Kistler-Tiffany Companies held 615 positions worth $264M, up 0.35% from $263M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kistler-Tiffany Companies's Q3 2019 filing shows 36 new, 119 increased, 95 reduced and 19 closed positions. Its largest new stake was Crown Holdings: 8,915 shares worth $589K. The largest sale was Mesa Laboratories, an estimated $6.49M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Staples.

  • Kistler-Tiffany Companies's largest Q3 2019 buy was Crown Holdings: 8,915 shares worth $589K.
  • Kistler-Tiffany Companies added most to West Pharmaceutical in Q3 2019, an estimated $3.36M increase.
  • Kistler-Tiffany Companies's biggest Q3 2019 reduction was Mesa Laboratories, cutting an estimated $6.49M.
  • Kistler-Tiffany Companies fully exited Invesco S&P MidCap 400 Pure Growth ETF in Q3 2019, selling an estimated $336K.
  • Kistler-Tiffany Companies's ten largest holdings make up 51% of its $264M portfolio in Q3 2019.
  • Kistler-Tiffany Companies opened 36 new positions and closed 19 in Q3 2019.
  • Kistler-Tiffany Companies's portfolio value rose 0.35% quarter-over-quarter to $264M.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2019, filed 18 Oct 2019.